MannKind News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.01.15	MannKind Earns $50 Mln In Milestone Payments From Sanofi (RTTNews)
03.11.14	MannKind Loss Narrows (RTTNews)
24.09.14	MannKind Closes Global Licensing Deal With Sanofi - Quick Facts (RTTNews)
11.08.14	MannKind Shares Soar On Deal With Sanofi On Afrezza; Q2 Loss Widens (RTTNews)
11.08.14	MÄRKTE USA/Wall Street dürfte Erholung fortsetzen (Dow Jones)
11.08.14	MannKind Q2 Loss Widens - Quick Facts (RTTNews)
11.08.14	Sanofi, MannKind To Launch Afrezza In U.S. In Q1, 2015 - Quick Facts (RTTNews)
12.05.14	MannKind Q1 Loss Widens; But Loss/shr Narrows - Quick Facts (RTTNews)
12.05.14	Mallinckrodt-Questcor Deal Receives U.S. Antitrust Approval - Quick Facts (RTTNews)
08.04.14	IMMU Chugs Along, MNKD Decision Delayed, QCOR Bought Out, Another First For ISR (RTTNews)
07.04.14	MannKind: FDA Extends PDUFA Date For Afrezza By Three Months To July 15 (RTTNews)
02.04.14	MÄRKTE USA/Rekordjagd könnte mit reduziertem Schwung anhalten (Dow Jones)
02.04.14	MNKD Breathes Easy, Arrowhead Well On Target, CPRX Awaits Next Catalyst (RTTNews)
18.02.14	MannKind Corp. Q4 Loss Misses Estimates (RTTNews)
13.01.14	ALNY Opens Wallet, MNKD Gets FDA Panel Date, STEM Keeps Growing (RTTNews)
10.01.14	MannKind: FDA Panel Meeting Tentatively Scheduled On April 1 For AFREZZA NDA (RTTNews)
30.10.13	FDA Acknowledges MannKind's Resubmission Of AFREZZA NDA - Quick Facts (RTTNews)
21.10.13	Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences (PR Newswire)
15.10.13	ATRS Hits A High, CNDO's TRUST Fails, KOOL Has Some Hot News, MNKD, PLX On Watch (RTTNews)
14.10.13	MannKind Resubmits NDA For AFREZZA For Treatment Of Diabetes - Quick Facts (RTTNews)
10.10.13	Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc. (PR Newswire)
23.09.13	Conference Calls, New Appointments, Upcoming Presentations, Prospectus Filings and Acquisition Deal Updates - Research Report on Johnson & Johnson, WellPoint, Regeneron, Onyx, and MannKind (PR Newswire)
10.09.13	Technical Scrutiny: Novavax Inc., MannKind Corp., Galena Biopharma Inc., and Ariad Pharma Inc. (PR Newswire)
10.09.13	Critical Alerts For Amazon, Gilead Sciences, Viacom, Broadcom, and MannKind Released By InvestorsObserver (PR Newswire)
06.09.13	Pre-market Movers For Sept 6 (PAY, ZQK, FNSR, AMBA, MNKD, LTXC, STND) (RTTNews)
03.09.13	Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation (PR Newswire)
28.08.13	Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray (PR Newswire)
19.08.13	Positive Preliminary Results, R&D Investments, and Financial Results - Research Report on MannKind, Anacor, Sangamo, Stereotaxis, and Columbia Laboratories (PR Newswire)
19.08.13	MNKD To Get Financing, PTIE, DRRX Vault, BMRN On Watch (RTTNews)
14.08.13	Pre-market Movers Aug 14 (AAPL, DE, MNKD, OSIR, CREE, MCOX) (RTTNews)
14.08.13	Quarterly Results, Collaborations and Product Launches - Research Report on Onyx Pharmaceuticals, Express Scripts, NPS Pharmaceuticals, Salix Pharmaceuticals, and MannKind Corporation (PR Newswire)
14.08.13	MannKind's Two Phase 3 Studies Of Afrezza Positive, Meet Primary End Points (RTTNews)
09.08.13	MannKind Q2 Loss Widens (RTTNews)
07.08.13	Critical Alerts For Starbucks, Nordstrom, Novo Nordisk, MannKind, and Westport Innovations Released By InvestorsObserver (PR Newswire)
02.08.13	Pre-Market Analysis: MannKind, Galena Biopharma, Ariad Pharma, and Novavax (PR Newswire)
02.10.09	AFRESA® Daten der Phase-III-Studie: nachhaltige Blutzuckereinstellung und normale Lungenfunktion bei Behandlungszeitraum von vier Jahren (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Kuehne+Nagel Int	205.10	1.64 %	K V
Roche Hldg G	267.50	0.79 %	K V
UBS Group	31.33	0.64 %	K V
Lonza Grp	557.40	0.54 %	K V
Givaudan	3’948.00	0.46 %	K V
Swiss Life Hldg	724.80	-0.08 %	K V
Swisscom	512.00	-0.10 %	K V
Geberit	504.60	-0.24 %	K V
Sonova Hldg	301.80	-0.26 %	K V
Zurich Insur Gr	534.80	-0.85 %	K V

Nachrichten zu MannKind Corp.

Aktien Top/Flop

Meistgelesene Nachrichten